Effects of herb-partitioned moxibustion and electroacupuncture on serum indexes of intestinal fibrosis in rats with Crohn’s disease

Journal of Acupuncture and Tuina Science - Tập 9 - Trang 13-16 - 2011
Yanbo Ren1, Cuihong Zhang1, Caiping An2, Huangan Wu1, Jue Hong1, Lingxiang Wu1, Jie Liu1, Xiaopeng Ma1
1Shanghai Research Institute of Acupuncture and Meridian, Shanghai, P. R. China
2Maternity Hospital, Fudan University, Shanghai, P. R. China

Tóm tắt

To observe the impact of herb-partitioned moxibustion and electroacupuncture on hyaluronic acid (HA), procollagen III (PC III) and collagen IV (C IV) of intestinal fibrosis in rats with Crohn’s disease (CD), and discuss the effect and the mechanism of acupuncture on treating intestinal fibrosis of rats. SD rats were randomly divided into control group, model group, herb-partitioned moxibustion group, electroacupuncture group and medicine group. The model of CD was developed by trinitrobenzene sulfonic acid. Masson stain was used to observe the collagen fibers hyperplasia in colon and radioimmunoassay was adopted to detect the content of HA, PC III and C IV in serum. Compared with the control group, the proliferation of colonic collagen fibers, as well as the HA, PC III and C IV in serum increased in the model group. Compared with the model group, the expression of collagen fibers, serum HA, PC III and C IV decreased in the herb-partitioned moxibustion group, electroacupuncture group and medicine group. The expression of collagen fibers serum HA, PC III and C IV in the herb-partitioned moxibustion group were lower than in the electroacupuncture group and medicine group. Herb-partitioned moxibustion and electroacupuncture effectively improved the pathological state of intestinal fibrosis in rats with CD and reduced the content of HA, PC III and C IV in serum.

Tài liệu tham khảo

Wu XN, Liu AQ. Detection, meaning and cause of intestinal fibrosis in Crohn’s disease. Chinese Journal of Digestion, 2007, 27(3): 210–211. Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G. TGF-beta and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta, 2009, 1793(8): 746–756. Ngo P, Ramalingam P, Phillips JA, Furuta GT. Collagen gel contraction assay. Methods Mol Biol, 2006, 341: 103–109. Spinelli A, Correale C, Szabo H, Montorsi M. Intestinal fibrosis in Crohn’s Disease: medical treatment or surgery. Curr Drug Targets, 2010, 11(2): 242–248. Wu HG, Zhang LS. Clinical study of herb-partitioned moxibustion on Crohn’s disease. Modern Rehabilitation, 2000, 4(3): 397. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology, 1989, 96(3): 795–803. Vallance BA, Gunawan MI, Hewlett B, Bercik P, Van Kampen C, Galeazzi F, Sime PJ, Gauldie J, Collins SM. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol, 2005, 289(1): G116–G128. Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, Hahn EG, Schuppan D. Acupuncture and moxibustion in the treatment of active Crohn’s disease: a randomized controlled study. Digestion, 2004, 69(3): 131–139. Ince MN, Elliott DE. Immunologic and molecular mechanisms in inflammatory bowel disease. Surg Clin North Am, 2007, 87(3): 681–696. Yu WH, Xu GQ. Mechanism of fibrosis and the change of serum fibrostic markers in Crohn’s disease. International Journal of Digestive Diseases 2009, 29(4): 235–263.